Karin Jordan
0000-0002-0879-3469
Publication & Citation Trends
Publications
0 total
694P Sequential high-dose-chemotherapy with 4 cycles paclitaxel, ifosfamide, carboplatin, etoposide (P-ICE) in relapsed/refractory male germ cell cancer: Final results with 15.8 years follow-up
Cited by 0
Semantic Scholar
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. OA
Cited by 77
Semantic Scholar
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial OA
Cited by 71
Semantic Scholar
Improvement of pain‐related self‐management for cancer patients through a modular transitional nursing intervention: A cluster‐randomized multicenter trial
Cited by 63
Semantic Scholar
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination
Cited by 35
Semantic Scholar
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study
Cited by 6
Semantic Scholar
Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.
Cited by 6
Semantic Scholar
Research Topics
Nausea and vomiting management
(62)
Anesthesia and Pain Management
(37)
Pathogenesis and Treatment of Hiccups
(28)
Chemotherapy-related skin toxicity
(10)
Cancer survivorship and care
(8)
Affiliations
Mayo Clinic
Merck (Germany)
Heidelberg University
Luther University
University Hospital Heidelberg